Used as a key intermediate in the synthesis of pharmaceutical compounds, particularly in the development of kinase inhibitors for cancer treatment. Its structure supports the design of bioactive molecules with enhanced binding affinity and selectivity. Commonly employed in medicinal chemistry research to optimize drug candidates targeting tyrosine kinases and other signaling proteins involved in tumor growth. Also utilized in the preparation of fluorinated analogs to improve metabolic stability and pharmacokinetic properties of new drug entities.